Astec LifeSciences Limited (NSE:ASTEC)
India flag India · Delayed Price · Currency is INR
556.30
+2.90 (0.52%)
Nov 17, 2026, 3:30 PM IST

Astec LifeSciences Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Revenue
4,3654,4573,7814,5776,2826,766
Other Revenue
24.3124.3131.579.413.313.34
4,3894,4813,8134,5866,2856,769
Revenue Growth
16.06%17.53%-16.86%-27.03%-7.15%21.16%
Cost of Revenue
2,9803,0833,0563,2494,0693,920
Gross Profit
1,4101,399757.21,3382,2162,849
Selling, General & Admin
642.32639.31621.68629533.27513.32
Other Operating Expenses
839.64803.79797.59762.03911.8788.77
Operating Expenses
1,9341,8921,8561,7541,7821,646
Operating Income
-524.84-493.82-1,099-415.94434.561,203
Interest Expense
-294.41-340.8-362.76-248.56-201.58-86.95
Interest & Investment Income
5.215.218.031.5140.492.63
Currency Exchange Gain (Loss)
11.9211.9215.949.7183.9272.45
Other Non Operating Income (Expenses)
10.7413.531.74-3.09-3.85-0.35
EBT Excluding Unusual Items
-791.38-803.97-1,436-616.37353.541,191
Gain (Loss) on Sale of Assets
-0.66-0.6620.18-1.11-5.240.14
Other Unusual Items
-20.94-20.94----
Pretax Income
-797.41-810-1,410-617.48349.471,211
Income Tax Expense
-2.05-1.24-62.78-148.5793.53312.43
Earnings From Continuing Operations
-795.37-808.76-1,347-468.91255.94898.83
Minority Interest in Earnings
-0.41-0.41-0.41-0.39-0.29-0.24
Net Income
-795.77-809.18-1,348-469.3255.65898.59
Net Income to Common
-795.77-809.18-1,348-469.3255.65898.59
Net Income Growth
-----71.55%38.14%
Shares Outstanding (Basic)
222120202020
Shares Outstanding (Diluted)
222120202020
Shares Change
10.96%9.18%0.01%0.02%0.04%0.05%
EPS (Basic)
-35.72-37.79-68.71-23.9313.0445.87
EPS (Diluted)
-35.72-37.79-68.71-23.9313.0445.85
EPS Growth
-----71.56%38.06%

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
573.74-862.44-302.21-1,253-426.03-803.74
Free Cash Flow Per Share
25.75-40.28-15.41-63.88-21.73-41.01
Dividend Per Share
---1.5001.5001.500
Dividend Growth
---0%0%0%
Gross Margin
32.11%31.21%19.86%29.17%35.26%42.09%
Operating Margin
-11.96%-11.02%-28.83%-9.07%6.91%17.78%
Profit Margin
-18.13%-18.06%-35.34%-10.23%4.07%13.28%
Free Cash Flow Margin
13.07%-19.25%-7.93%-27.32%-6.78%-11.87%
EBITDA
-80.66-52.8-670.07-61.53759.351,536
EBITDA Margin
-1.84%-1.18%-17.57%-1.34%12.08%22.70%
D&A For EBITDA
444.18441.02429.14354.41324.79332.88
EBIT
-524.84-493.82-1,099-415.94434.561,203
EBIT Margin
-11.96%-11.02%-28.83%-9.07%6.91%17.78%
Effective Tax Rate
----26.76%25.79%
Revenue as Reported
4,4374,5323,8694,6386,4126,870